Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Detection and Analysis of Circulating Tumor Cells (CTCs) in Patients With Breast Cancer Using a Novel Microfluidic and Raman Spectrum Device

NCT04239105 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT04239105
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04239105 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Detection and Analysis of Circulating Tumor Cells (CTCs) in Patients With Breast Cancer Using a Novel Microfluidic and Raman Spectrum Device
Lead sponsor
Xijing Hospital
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2020
Completion date
December 31, 2022
Enrollment
120 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms, circulating tumor cells